Clinical trial
Omega-3 Fatty Acids for Treatment of Major Depression: Differential Effects of EPA and DHA, and Associated Biochemical and Immune Parameters
NCT00361374 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omega-3 Fatty Acids for Treatment of Major Depression: Differential Effects of EPA and DHA, and Associated Biochemical and Immune Parameters
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- March 31, 2013
- Enrollment
- 196 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.